Rapid Development of a Mucosal Nanoparticle Flu Vaccine by Genetic Engineering of Bacteriophage T4 using CRISPR-Cas
Preprint
- 14 June 2022
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Mucosal vaccines that can induce local mucosal immune responses and combat the pathogens at entry sites are considered to be the most effective way to prevent infection. A universal platform that can be customized for development of mucosal vaccines against any given pathogen is therefore highly desired. Here, we demonstrate an efficient approach to develop nasal mucosal vaccines through genetic engineering of T4 phage to generate antigen-decorated nanoparticles. The antigen coding sequence was inserted into T4 genome in-frame at the C terminus of Soc (small outer capsid protein) using the CRISPR-Cas phage editing technology. During the propagation of recombinant T4 phages in E. coli, the Soc-antigen fusion proteins self-assemble on T4 capsids to form antigen-decorated nanoparticles that have intrinsic adjuvant activity and mucosal adhesive property. As a proof of concept, we showed that intranasal immunization with Flu viral M2e-decorated T4 nanoparticles efficiently induced local mucosal as well as systemic immune responses and provided complete protections against divergent influenza viruses in a mouse model. Potentially, our platform can be customized for any respiratory pathogen to rapidly generate mucosal vaccines against future emerging epidemics and pandemics.Keywords
This publication has 56 references indexed in Scilit:
- Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague VaccinesPLoS Pathogens, 2013
- Migratory properties of pulmonary dendritic cells are determined by their developmental lineageMucosal Immunology, 2013
- Bacteriophage adhering to mucus provide a non–host-derived immunityProceedings of the National Academy of Sciences of the United States of America, 2013
- Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus InfectionThe Journal of Immunology, 2011
- Nanoparticle Delivery Systems in Cancer VaccinesPharmaceutical Research, 2010
- Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infectionThe Journal of Experimental Medicine, 2010
- Phenotypic Definition of Effector and Memory T-Lymphocyte Subsets in Mice Chronically Infected withMycobacterium tuberculosisClinical and Vaccine Immunology, 2010
- Structure of the Small Outer Capsid Protein, Soc: A Clamp for Stabilizing Capsids of T4-like PhagesJournal of Molecular Biology, 2010
- Coexpression of CD25 and OX40 (CD134) Receptors Delineates Autoreactive T-cells in Type 1 DiabetesDiabetes, 2006
- Intranasal Influenza Vaccine in a Working PopulationClinical Infectious Diseases, 2004